This Inflammation Play Might Be the Heart of Your Next Big Trade

One overlooked biotech just delivered clinical results that reignited hopes for an anti-inflammatory breakthrough in heart disease.

With key biomarkers moving fast, this stock may be entering a much bigger arena than weight loss.

Your portfolio doesn’t need dozens of winners.

Sometimes, just a few right picks can do the heavy lifting.

That’s the thinking behind our newest report: 5 Stocks Set to Double.

These companies were chosen because they combine:

And while no outcome can be guaranteed, previous reports like this have spotlighted stocks before massive moves +175%, +498%, even +673%.¹

Now, you can get the latest edition absolutely free—until midnight tonight.

[Click here to download instantly]

This window won’t stay open. Act now.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Wall Street rebounded as easing U.S.-China trade tensions and confirmation of a Trump–Xi meeting boosted market sentiment, with tech leading the recovery from Wednesday’s dip.

Apple Inc. (NASDAQ: AAPL) just took a major hit in the U.K., where a tribunal ruled it overcharged developers through the App Store.

You’ll feel the ripple effect, because this fight is about who controls the digital storefront of the modern world.

The ruling could cost Apple up to $2 billion and open the door for more countries to question how it manages app fees.

You can expect global regulators to take notes and move fast as the world’s biggest tech firm faces new accountability.

The App Store’s Billion-Dollar Problem

Apple’s App Store has long been a cash machine, driving $90 billion in annual revenue.

That’s why regulators see it as a pressure point, one that shapes how every app, subscription, and digital product reaches you.

If the U.S. or Europe mirrors the U.K.’s ruling, Apple’s services division could face structural change. For a company built on control, that’s a major strategic test.

Adapting to a New Reality

Apple’s appeal will drag on, but the damage may already be done in perception.

If Apple fails to adjust, its biggest moneymaker could also become its biggest liability, and you might be watching the start of a slow shift in how the company builds trust with both users and regulators.

United Airlines (NASDAQ: UAL) is catching serious tailwinds after posting one of its strongest quarters in years.

You can see the momentum in every chart: rising demand, lower fuel costs, and a confident management team that just approved nearly $600 million in stock buybacks.

The company’s results show a clear picture of recovery that’s built on execution, not hype.

As the U.S. dollar strengthens and domestic travel rebounds, United is reclaiming altitude in both market share and investor attention.

Flying on Fundamentals, Not Fuel

Fuel prices have dropped, but that’s not the whole story.

United’s real power comes from premium bookings, steady load factors, and its growing footprint on profitable international routes, the stuff that matters when you’re judging staying power, not short-term turbulence.

Add in a disciplined cost structure, and you have an airline that’s finally running leaner and smarter.

You can feel the difference in how investors are reacting, patient, confident, and quietly bullish.

The Runway Still Looks Clear

United’s brighter outlook has people watching to see how high it can climb next year.

The setup feels simple, with cheaper fuel, steady demand, and a stronger dollar giving the airline a fresh lift.

If you’re looking for a travel stock that actually rewards you for boarding early, this might be it.

United has turned its turnaround story into something that finally feels ready for takeoff.

Most people didn’t realize it, but history was made in July.

Congress passed the GENIUS Act — the first real federal crypto framework in U.S. history.

And with President Trump signing it, America officially became the “crypto capital of the planet.”

What does that mean?

Our free Crypto Revolution book shows you exactly how to position yourself now — before institutional money makes this mainstream.

[Get your free copy + bonuses here]

© 2025 Boardwalk Flock LLC. All Rights Reserved. 2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States

The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.

Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.

Nike (NYSE: NKE) is firing up its innovation engine again with Project Amplify, a futuristic line that blurs the line between sportswear and robotics.

You can almost picture it, a sneaker that gives you a literal boost every step of the way.

Built with help from bionic firm Dephy, the project introduces a lightweight, attachable motor to help both athletes and everyday users move more efficiently.

It’s Nike’s loudest statement yet that performance tech —not just fashion collabs —will drive its next decade.

From Sweat to Sensors

The new lineup also includes Mind 001 and Mind 002, shoes that claim to sharpen focus through underfoot sensory feedback, and Aero-FIT, a smart cooling jersey debuting at the next World Cup.

Together, they mark a pivot from retail hustle to true product innovation, the kind you can feel.

For you, that means Nike’s no longer chasing hype; it’s chasing breakthroughs that actually make movement smarter.

The company seems ready to turn performance gear into performance tech.

The Next Frontier of Athletic Power

Nike’s bet is simple. If it can merge biomechanics, AI, and design into a single product line, the payoff could redefine what athletic gear means to you.

Project Amplify isn’t about keeping pace; it’s about creating a new race entirely.

After years of coasting on branding, this feels like Nike’s moonshot moment. The swoosh might just stand for speed again.

👉 Click here to get our closing report to your cell for free!

Ventyx Biosciences Inc [VTYX] $6.60 (+70.98%)

Ventyx Biosciences surged after its mid‑stage trial showed strong reductions in inflammatory and liver disease markers, supporting its NLRP3‑targeting strategy for cardiovascular risk.

Brera Holdings Plc [SLMT] $11.41 (+36.65%)

Brera jumped after securing a waiver and consent deal with key security holders, easing filing deadlines and extending its SEC registration timeline.

Core Laboratories Inc [CLB] $16.47 (+28.97%)

Core Laboratories advanced after reporting quarterly earnings and revenue above Wall Street estimates, signaling stronger performance in its energy services segment.

Integer Holdings Corp [ITGR] $73.86 (-32.30%)

Integer slipped despite beating earnings estimates, as weak guidance and underperformance in a key cardiac division raised concerns about future growth.

Molina Healthcare Inc [MOH] $161.01 (-17.49%)

Molina plunged over 20% after a massive earnings miss and lowered guidance revealed worsening margins from surging medical costs in ACA plans.

The Simply Good Foods Company [SMPL] $20.69 (-17.11%)

Simply Good Foods declined after missing earnings estimates and reporting a continued drop in year-over-year revenue.

Every month, we screen thousands of companies through our proprietary earnings-based ranking system.

The majority fail. Only a handful pass. And then, our analysts hand-select the best of the best.

This month, just 7 stocks made the cut — and we’re giving you their names for free.

These stocks share three things in common:

With volatility at highs, this focused list could be the most important set of trades you make all year.

[Get your free copy of the 7 Best Stocks to Own Now.]

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.